Check-Cap’s cancer screening capsule will have U.S. study

Check-Cap (NSDQ:CHEK) said its X-ray-enabled, colorectal cancer-screening capsule will have a pilot study in the United States.

The Isfiya, Israel-based startup makes the C-Scan System, an ingestible capsule used to detect precancerous polyps without the need for laxatives or an invasive procedure. The C-Scan system uses an ultra-low dose X-ray capsule, an integrated positioning, control, and recording system, and proprietary software to generate a 3D map of the inner lining of the colon. It received approval from Israel’s Ministry of Health Medical Device division (AMAR) and the CE Mark in 2018.

Get the full story on our sister site, Medical Design & Outsourcing.

The post Check-Cap’s cancer screening capsule will have U.S. study appeared first on MassDevice.

from MassDevice http://bit.ly/2GntWE4